Late rectal complications after prostate brachytherapy for localized prostate cancer : Incidence and management
โ Scribed by Jack Phan; David A. Swanson; Lawrence B. Levy; Rajat J. Kudchadker; Teresa L. Bruno; Steven J. Frank
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 236 KB
- Volume
- 115
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Prostate brachytherapy is an effective treatment option for clinically organ-confined prostate carcinoma. Observed 5-and 10-year follow-up have documented prostate-specific antigen (PSA) levels that were comparable to published radical prostatectomy series and were better than several published exte
BACKGROUND. Brachytherapy (BT) has seen increased utilization as a potentially curative treatment for patients with localized initial or recurrent prostate carcinoma. This modality can be delivered by palladium 103 (Pd 103 ) or iodine 125 (I 125 ) implant with or without external beam radiotherapy (
## Abstract Depending on initial prognostic factors, an estimated 10%โ60% of men who undergo definitive radiation therapy for prostate cancer may experience a biochemical recurrence. Even though hormonal therapy is standard for metastatic recurrences, no consensus exists on optimal salvage therapy
In recent years, there has been a resurgence of interest in interstitial radiation as a cost-effective and efficient method of treating organ-confined prostate cancer. We describe our 7- and 8-year results with transperineal Iodine-125 and Palladium-103 implantation. A total of 551 consecutive patie